Pamela L. Lyle

<i>BRAF</i> L597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors

Kimberly B. Dahlman, Junfeng Xia, Katherine E. Hutchinson et al. · Cancer Discovery · 2012 · 199 citations

Medicine, Genetics, Oncology +17

BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition

Katherine E. Hutchinson, Doron Lipson, Philip J. Stephens et al. · Clinical Cancer Research · 2013 · 177 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Gastrointestinal Melanoma or Clear Cell Sarcoma? Molecular Evaluation of 7 Cases Previously Diagnosed as Malignant Melanoma

Pamela L. Lyle, Carol M. Amato, James E. Fitzpatrick et al. · The American Journal of Surgical Pathology · 2008 · 78 citations

Medicine, Oncology, Pathology +17

Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers

Nicole Balmer, Jennifer K. Richer, Nicole S. Spoelstra et al. · Modern Pathology · 2006 · 63 citations · Full text

Medicine, Gynecology, Pathology +17

Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with <i><scp>MDM</scp>2</i> or <i><scp>CDK</scp>4</i> amplification

Pamela L. Lyle, Julia A. Bridge, Jean F. Simpson et al. · Histopathology · 2015 · 41 citations

Veterinary Medicine, Oncology, Pathology +16